Back
#1
23.0%
Top 65%
8.1%
Top 1%
8.1%
Top 42%
6.2%
Top 0.9%
5.2%
Top 0.6%
4.0%
Top 0.4%
2.2%
Top 7%
2.0%
Top 5%
2.0%
Top 0.6%
2.0%
Top 20%
2.0%
#1
1.6%
Top 46%
1.4%
Top 1%
1.4%
Top 18%
1.0%
Top 11%
1.0%
Top 2%
0.7%
Top 6%
0.7%
Top 12%
0.7%
Top 13%
0.7%
Allogenic Megakaryocyte Therapy in patients with Refractory Thrombocytopenia
2025-10-09
hematology
Title + abstract only
View on medRxiv
Show abstract
BACKGROUNDPatients with refractory thrombocytopenia (RT) are not sensitive to conventional therapies, such as platelet transfusions and thrombopoietin receptor agonists (TPO-RAs). The persistently high risk of life-threatening hemorrhage in this population highlights the urgent need for novel therapeutic strategies. Megakaryocyte (MK)-based therapies have emerged as a promising alternative, as MKs are the natural precursor cells responsible for platelet production. However, whether allogeneic MK...
Predicted journal destinations
1
Blood Advances
16 training papers
2
PLOS ONE
1737 training papers
3
Frontiers in Immunology
140 training papers
4
Scientific Reports
701 training papers
5
JCI Insight
63 training papers
6
Journal of Clinical Investigation
50 training papers
7
Cell
28 training papers
8
Frontiers in Medicine
99 training papers
9
Proceedings of the National Academy of Sciences
100 training papers
10
Science Translational Medicine
40 training papers
11
eLife
262 training papers
12
Infectious Diseases and Therapy
18 training papers
13
Nature Communications
483 training papers
14
Science Advances
52 training papers
15
Journal of Clinical Medicine
77 training papers
16
Vaccines
131 training papers
17
Biomedicines
21 training papers
18
Diagnostics
36 training papers
19
iScience
74 training papers
20
Heliyon
57 training papers